Catalyst
Slingshot members are tracking this event:
Acadia (ACAD) Announces Initiation of Phase 2 Study Evaluating Pimavanserin in Alzheimer's Disease Agitation
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ACAD |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 31, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Trial Initiation, Pimavanserin, Alzheimer's Disease Agitation
